| NCT03292341 |
Evaluation of a Web-based Decision Aid Tool for Larynx Cancer (T3/T4) Patients. |
https://ClinicalTrials.gov/show/NCT03292341 |
Recruiting |
Maastricht Radiation Oncology |
2020-05-31 |
| NCT03114462 |
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer |
https://ClinicalTrials.gov/show/NCT03114462 |
Recruiting |
M.D. Anderson Cancer Center |
2027-08-31 |
| NCT03096808 |
Adaptive Radiotherapy for Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT03096808 |
Active, not recruiting |
Memorial Sloan Kettering Cancer Center |
2021-03-15 |
| NCT03082534 |
Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT03082534 |
Recruiting |
University of California, San Diego |
2019-12-30 |
| NCT03010813 |
A Novel Robotic System for Single Port and Natural Orifice Transluminal Endoscopic Surgery |
https://ClinicalTrials.gov/show/NCT03010813 |
Completed |
Chinese University of Hong Kong |
2017-10-31 |
| NCT02849314 |
Combination of Cryosurgey and NK Immunotherapy for Recurrent Laryngeal Cancer |
https://ClinicalTrials.gov/show/NCT02849314 |
Completed |
Fuda Cancer Hospital, Guangzhou |
2017-07-01 |
| NCT02757222 |
Dose Escalation Versus Standard in Laryngopharyngeal Cancers |
https://ClinicalTrials.gov/show/NCT02757222 |
Recruiting |
Tata Medical Center |
2020-12-31 |
| NCT02734537 |
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery |
https://ClinicalTrials.gov/show/NCT02734537 |
Recruiting |
Eastern Cooperative Oncology Group |
2022-05-01 |
| NCT02586207 |
Pembrolizumab in Combination With CRT for LA-SCCHN |
https://ClinicalTrials.gov/show/NCT02586207 |
Active, not recruiting |
Sanford Health |
2020-06-30 |
| NCT03392220 |
A Multicenter, Randomized, Case-control Study of Unilateral vs Bilateral Neck Dissection for cN0 Supraglottic Laryngeal Cancer |
https://ClinicalTrials.gov/show/NCT03392220 |
Recruiting |
Cancer Institute and Hospital, Chinese Academy of Medical Sciences |
2020-09-30 |
| NCT02430675 |
Irreversible Electroporation(IRE) For Unresectable Laryngeal Neoplasms |
https://ClinicalTrials.gov/show/NCT02430675 |
Recruiting |
Fuda Cancer Hospital, Guangzhou |
2020-12-01 |
| NCT02229656 |
Olaparib and Radiotherapy in Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT02229656 |
Active, not recruiting |
The Netherlands Cancer Institute |
2020-01-14 |
| NCT02217358 |
Value of Narrow Band Imaging (NBI) Endoscopy in the Early Diagnosis of Laryngeal Cancer and Precancerous Lesions |
https://ClinicalTrials.gov/show/NCT02217358 |
Completed |
University Hospital Ostrava |
2016-03-31 |
| NCT02198131 |
Pulsed Dye Laser in Treating Patients With Post Radiation Dysphonia |
https://ClinicalTrials.gov/show/NCT02198131 |
Completed |
Wake Forest University Health Sciences |
2016-06-30 |
| NCT02177838 |
Cetuximab and Radiation Therapy in Treating Patients With Stage III-IV Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT02177838 |
Recruiting |
Rutgers, The State University of New Jersey |
2020-06-01 |
| NCT02156518 |
The Efficacy of Vocal Function Exercises for Laryngeal Cancers |
https://ClinicalTrials.gov/show/NCT02156518 |
Completed |
University of Kentucky |
2018-01-31 |
| NCT02123511 |
Acetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoing Radiation Therapy |
https://ClinicalTrials.gov/show/NCT02123511 |
Completed |
Mayo Clinic |
2016-03-22 |
| NCT01316757 |
Carboplatin, Paclitaxel, Cetuximab, and Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Head and Neck Squamous Cell Cancer |
https://ClinicalTrials.gov/show/NCT01316757 |
Completed |
Fox Chase Cancer Center |
2015-04-07 |
| NCT02048020 |
Paclitaxel and Carboplatin Before Radiation Therapy With Paclitaxel in Treating HPV-Positive Patients With Stage III-IV Oropharynx, Hypopharynx, or Larynx Cancer |
https://ClinicalTrials.gov/show/NCT02048020 |
Completed |
Jonsson Comprehensive Cancer Center |
2017-01-09 |
| NCT02035527 |
Sorafenib Tosylate, Cisplatin, and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck |
https://ClinicalTrials.gov/show/NCT02035527 |
Completed |
Ohio State University Comprehensive Cancer Center |
2017-04-20 |
| NCT03174275 |
Carboplatin, Nab-Paclitaxel, Durvalumab Before Surgery and Adjuvant Therapy in Head and Neck Squamous Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT03174275 |
Recruiting |
UNC Lineberger Comprehensive Cancer Center |
2021-09-01 |
| NCT03258554 |
Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin |
https://ClinicalTrials.gov/show/NCT03258554 |
Recruiting |
National Cancer Institute (NCI) |
2025-12-31 |
| NCT01984502 |
CyberKnife Accelerated Hemilarynx Stereotactic Radiotherapy Study for Early-stage Glottic Larynx Cancer |
https://ClinicalTrials.gov/show/NCT01984502 |
Recruiting |
University of Texas Southwestern Medical Center |
2023-12-31 |
| NCT01884259 |
Induction Chemotherapy With TP+5-FU or TP+Cetuximab Followed by Radioimmuptherapy for Locally Advanced or Not Resectable SCCHNN |
https://ClinicalTrials.gov/show/NCT01884259 |
Active, not recruiting |
Arbeitsgemeinschaft medikamentoese Tumortherapie |
2021-01-31 |
| NCT01847326 |
Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin Followed By Chemoradiation in Treating Patients With Recurrent Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT01847326 |
Recruiting |
University of Chicago |
2021-04-30 |
| NCT01810913 |
Radiation Therapy With Cisplatin, Docetaxel, or Cetuximab After Surgery in Treating Patients With Stage III-IV Squamous Cell Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT01810913 |
Active, not recruiting |
National Cancer Institute (NCI) |
2027-01-01 |
| NCT01806675 |
18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy |
https://ClinicalTrials.gov/show/NCT01806675 |
Completed |
Stanford University |
2016-12-07 |
| NCT01637194 |
Cetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT01637194 |
Completed |
Fox Chase Cancer Center |
2011-07-31 |
| NCT01633541 |
Chemotherapy AND Bcl-xL Inhibitor (AT-101) For Organ Preservation In Adults With Advanced Laryngeal Cancer |
https://ClinicalTrials.gov/show/NCT01633541 |
Active, not recruiting |
University of Michigan Rogel Cancer Center |
2021-11-30 |
| NCT01626638 |
Confocal Micro-endoscopy in Head and Neck Cancer/Micro Endoscopie Confocale (MEC)Oto-Rhino-Laryngologie (ORL) |
https://ClinicalTrials.gov/show/NCT01626638 |
Completed |
Gustave Roussy, Cancer Campus, Grand Paris |
2017-05-24 |
| NCT01473784 |
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck |
https://ClinicalTrials.gov/show/NCT01473784 |
Recruiting |
Ohio State University Comprehensive Cancer Center |
2020-12-31 |
| NCT01469429 |
Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer. |
https://ClinicalTrials.gov/show/NCT01469429 |
Completed |
Ohio State University Comprehensive Cancer Center |
2014-09-17 |
| NCT01445405 |
Radiation Therapy and Bortezomib and Cetuximab With or Without Cisplatin to Treat Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT01445405 |
Completed |
National Institutes of Health Clinical Center (CC) |
2010-08-27 |
| NCT01435252 |
A Phase II Study In Patients With Advanced Head And Neck Cancer Of Standard Chemoradiation And Add-On Cetuximab |
https://ClinicalTrials.gov/show/NCT01435252 |
Completed |
University of Zurich |
2017-10-25 |
| NCT01365169 |
Post-op Wellness Program for Pancreatic Cancer Patients That Uses Patient Feedback and Real-time Provider Monitoring |
https://ClinicalTrials.gov/show/NCT01365169 |
Recruiting |
M.D. Anderson Cancer Center |
2025-02-25 |
| NCT01334177 |
TLR8 Agonist VTX-2337 and Cetuximab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Squamous Cell Cancer of Head and Neck |
https://ClinicalTrials.gov/show/NCT01334177 |
Completed |
University of Washington |
2014-06-30 |
| NCT01332682 |
Resistance Training and Physical Functioning in Head and Neck Cancer Patients |
https://ClinicalTrials.gov/show/NCT01332682 |
Completed |
University of Alabama at Birmingham |
2010-12-31 |
| NCT04278638 |
IORT in Local Advanced Laryngocarcinoma |
https://ClinicalTrials.gov/show/NCT04278638 |
Recruiting |
Tianjin First Central Hospital |
2022-07-01 |
| NCT04174950 |
Perioperative ERAS Based Nursing Intervention for Laryngeal Cancer Patients |
https://ClinicalTrials.gov/show/NCT04174950 |
Recruiting |
Second Affiliated Hospital, School of Medicine, Zhejiang University |
2020-06-30 |
| NCT04110249 |
Photoacoustic Imaging for Measuring Tumors and Normal Tissue in Patients With Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT04110249 |
Recruiting |
Roswell Park Cancer Institute |
2020-07-13 |
| NCT04057209 |
VoiceS: Voice Quality After Transoral CO2-Laser Surgery Versus Single Vocal Cord Irradiation for Larynx Cancer |
https://ClinicalTrials.gov/show/NCT04057209 |
Recruiting |
University Hospital Inselspital, Berne |
2023-11-30 |
| NCT04030455 |
Cisplatin, Docetaxel, and Pembrolizumab in Treating Patients With Stage II-III Laryngeal Cancer |
https://ClinicalTrials.gov/show/NCT04030455 |
Recruiting |
M.D. Anderson Cancer Center |
2021-10-31 |
| NCT03759431 |
Vocal-cord vs. Complete Laryngeal Radiotherapy for Early Glottic Cancer |
https://ClinicalTrials.gov/show/NCT03759431 |
Recruiting |
Centre hospitalier de l’Université de Montréal (CHUM) |
2024-12-12 |
| NCT03653039 |
Comparison Between a Standard Tube and the Ultra-thin Tritube for Intubation of the Trachea and for Maintaining Access to the Trachea After Anaesthesia, in Patients With an Expected Difficult Direct Laryngoscopy |
https://ClinicalTrials.gov/show/NCT03653039 |
Recruiting |
Rigshospitalet, Denmark |
2019-03-31 |
| NCT03602079 |
Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene |
https://ClinicalTrials.gov/show/NCT03602079 |
Recruiting |
Klus Pharma Inc. |
2020-10-31 |
| NCT03548285 |
Stereotactic Ablative Radiotherapy for Early-stage Glottic Larynx Cancer |
https://ClinicalTrials.gov/show/NCT03548285 |
Recruiting |
University of Texas Southwestern Medical Center |
2021-12-31 |
| NCT01155609 |
L-lysine in Treating Oral Mucositis in Patients Undergoing Radiation Therapy With or Without Chemotherapy For Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT01155609 |
Completed |
University of Washington |
2011-12-31 |
| NCT01045057 |
Clinical Feasibility of New Tracheoesophageal Puncture Set |
https://ClinicalTrials.gov/show/NCT01045057 |
Completed |
Atos Medical AB |
2011-03-31 |
| NCT01044433 |
Capecitabine and Lapatinib Ditosylate in Treating Patients With Squamous Cell Cancer of the Head and Neck |
https://ClinicalTrials.gov/show/NCT01044433 |
Completed |
Abramson Cancer Center of the University of Pennsylvania |
2015-09-24 |
| NCT00970502 |
Erlotinib, Celecoxib and Reirradiation for Recurrent Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT00970502 |
Completed |
Icahn School of Medicine at Mount Sinai |
2010-11-30 |
| NCT00939627 |
Phase II Randomized Trial of the Combination of Cetuximab and Sorafenib or Single Agent Cetuximab |
https://ClinicalTrials.gov/show/NCT00939627 |
Completed |
National Cancer Institute (NCI) |
2013-01-31 |
| NCT00827164 |
Resistance Training During Radiation Therapy for Pharyngeal or Laryngeal Cancer |
https://ClinicalTrials.gov/show/NCT00827164 |
Completed |
University of Alabama at Birmingham |
2015-04-30 |
| NCT03028766 |
WEE1 Inhibitor With Cisplatin and Radiotherapy: A Trial in Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT03028766 |
Active, not recruiting |
University of Birmingham |
2019-10-31 |
| NCT04162873 |
Celecoxib Through Surgery and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT04162873 |
Recruiting |
University of Utah |
2024-10-12 |
| NCT00765011 |
TPF Plus Radiotherapy and Cetuximab to Avoid Total Laryngectomy in Patients With Larynx Cancer |
https://ClinicalTrials.gov/show/NCT00765011 |
Completed |
Grupo Español de Tratamiento de Tumores de Cabeza y Cuello |
2014-02-28 |
| NCT00721799 |
F-18 Fluorothymidine PET Imaging for Early Evaluation of Response to Therapy in Head & Neck Cancer Patients |
https://ClinicalTrials.gov/show/NCT00721799 |
Completed |
University of Iowa |
2014-12-31 |
| NCT00593840 |
Phase II Trial Evaluating Elimination of Radiation Therapy |
https://ClinicalTrials.gov/show/NCT00593840 |
Active, not recruiting |
Washington University School of Medicine |
2014-02-28 |
| NCT00576134 |
The Objective is to Respond to Patients’ Needs in the Field of Larynx Replacement |
https://ClinicalTrials.gov/show/NCT00576134 |
Completed |
University Hospital, Strasbourg, France |
2013-08-31 |
| NCT00534729 |
Organ Preservation: Weekly Carboplatin & Taxol w/Concurrent RT for Locally Advanced Laryngeal & Hypopharyngeal CA |
https://ClinicalTrials.gov/show/NCT00534729 |
Completed |
King Faisal Specialist Hospital & Research Center |
2015-09-30 |
| NCT00513435 |
Saracatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT00513435 |
Completed |
National Cancer Institute (NCI) |
2011-03-31 |
| NCT00507767 |
Dasatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT00507767 |
Completed |
National Cancer Institute (NCI) |
2010-02-28 |
| NCT00492089 |
Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT00492089 |
Completed |
National Cancer Institute (NCI) |
2010-08-31 |
| NCT00470496 |
Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT00470496 |
Completed |
Roswell Park Cancer Institute |
2011-10-28 |
| NCT00467948 |
Comparison of 2 Cefazolin Prophylactic Protocol in Laryngectomy Patients |
https://ClinicalTrials.gov/show/NCT00467948 |
Completed |
Tehran University of Medical Sciences |
NA |
| NCT00462735 |
Fluorouracil, Hydroxyurea, Cetuximab and Twice-daily Intensity Radiation Therapy for Advanced Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT00462735 |
Completed |
Icahn School of Medicine at Mount Sinai |
2010-10-31 |
| NCT00410826 |
Cisplatin and Radiation Therapy With or Without Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT00410826 |
Completed |
University of Washington |
2012-05-31 |
| NCT00397384 |
Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer |
https://ClinicalTrials.gov/show/NCT00397384 |
Completed |
National Cancer Institute (NCI) |
2013-06-30 |
| NCT00387335 |
Sunitinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT00387335 |
Completed |
National Cancer Institute (NCI) |
2010-03-31 |
| NCT00169247 |
Radiotherapy With Cisplatin Versus Radiotherapy With Cetuximab After Induction Chemotherapy for Larynx Preservation |
https://ClinicalTrials.gov/show/NCT00169247 |
Completed |
Groupe Oncologie Radiotherapie Tete et Cou |
2011-04-30 |
| NCT00169182 |
Induction CT by Cisplatin, 5FU With or Without Docetaxel in Patients With T3 and T4 Larynx and Hypopharynx Carcinoma |
https://ClinicalTrials.gov/show/NCT00169182 |
Completed |
Groupe Oncologie Radiotherapie Tete et Cou |
2009-04-30 |
| NCT00162708 |
Very Intense Radiotherapy-Chemotherapy Regimen in Advanced HNSCC |
https://ClinicalTrials.gov/show/NCT00162708 |
Completed |
Gustave Roussy, Cancer Campus, Grand Paris |
NA |
| NCT00158652 |
Accelerated Radiotherapy and Concomitant Chemo-radiotherapy in HNSCC |
https://ClinicalTrials.gov/show/NCT00158652 |
Completed |
Groupe Oncologie Radiotherapie Tete et Cou |
2011-03-31 |
| NCT00127465 |
Investigating the Impact of Tailored Reports on Anxiety Amongst Cancer Patients and Their Confidants |
https://ClinicalTrials.gov/show/NCT00127465 |
Completed |
University of Plymouth |
NA |
| NCT00117572 |
Docetaxel Based Chemotherapy Plus or Minus Induction Chemotherapy to Decrease Events in Head and Neck Cancer (DeCIDE) |
https://ClinicalTrials.gov/show/NCT00117572 |
Completed |
University of Chicago |
2016-12-31 |
| NCT00114283 |
Lapatinib Ditosylate in Treating Patients With Metastatic or Recurrent Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT00114283 |
Completed |
National Cancer Institute (NCI) |
2006-10-31 |
| NCT00103259 |
Bortezomib With or Without Irinotecan in Treating Patients With Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck |
https://ClinicalTrials.gov/show/NCT00103259 |
Completed |
National Cancer Institute (NCI) |
2011-11-30 |
| NCT00101348 |
Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00101348 |
Completed |
National Cancer Institute (NCI) |
2007-10-31 |
| NCT00098631 |
Lapatinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT00098631 |
Completed |
National Cancer Institute (NCI) |
2006-12-31 |
| NCT00096512 |
S0420, Sorafenib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT00096512 |
Completed |
National Cancer Institute (NCI) |
2006-05-31 |
| NCT00095628 |
SB-715992 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT00095628 |
Completed |
National Cancer Institute (NCI) |
2010-07-31 |
| NCT00089362 |
Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors |
https://ClinicalTrials.gov/show/NCT00089362 |
Completed |
National Cancer Institute (NCI) |
2008-01-31 |
| NCT00004074 |
Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu |
https://ClinicalTrials.gov/show/NCT00004074 |
Completed |
National Cancer Institute (NCI) |
2009-02-28 |
| NCT00068497 |
Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00068497 |
Completed |
National Cancer Institute (NCI) |
2007-12-31 |
| NCT00004256 |
Sargramostim to Prevent Mucositis in Patients Receiving Radiation Therapy for Laryngeal Cancer |
https://ClinicalTrials.gov/show/NCT00004256 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00063895 |
Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carcinoma of the Head and Neck |
https://ClinicalTrials.gov/show/NCT00063895 |
Completed |
National Cancer Institute (NCI) |
2005-10-31 |
| NCT00055913 |
Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT00055913 |
Completed |
National Cancer Institute (NCI) |
2007-09-30 |
| NCT00055770 |
Erlotinib Plus Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT00055770 |
Completed |
National Cancer Institute (NCI) |
2006-12-31 |
| NCT00049283 |
Erlotinib, Docetaxel, and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT00049283 |
Completed |
National Cancer Institute (NCI) |
2008-02-29 |
| NCT00033618 |
Ixabepilone in Treating Patients With Metastatic or Recurrent Squamous Cell Cancer of the Head and Neck |
https://ClinicalTrials.gov/show/NCT00033618 |
Completed |
National Cancer Institute (NCI) |
2007-01-31 |
| NCT00031681 |
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) |
https://ClinicalTrials.gov/show/NCT00031681 |
Completed |
National Cancer Institute (NCI) |
2011-01-31 |
| NCT00030498 |
Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction |
https://ClinicalTrials.gov/show/NCT00030498 |
Completed |
National Cancer Institute (NCI) |
2007-07-31 |
| NCT00023959 |
Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT00023959 |
Completed |
National Cancer Institute (NCI) |
2010-03-31 |
| NCT00026975 |
Efficacy of Hyperbaric Oxygen Therapy in Laryngectomy Patients |
https://ClinicalTrials.gov/show/NCT00026975 |
Completed |
National Center for Complementary and Integrative Health (NCCIH) |
NA |
| NCT00359645 |
Randomized Trial to Assess the Impact of a Screening Program on Upper Aerodigestive Tract Cancer Mortality in a High Risk Population |
https://ClinicalTrials.gov/show/NCT00359645 |
Completed |
Gustave Roussy, Cancer Campus, Grand Paris |
2015-12-18 |